PRESS RELEASE published on 06/14/2023 at 18:20, 3 years ago EQS-Adhoc: Blue Cap AG signs agreement to sell Uniplast Group
PRESS RELEASE published on 05/09/2023 at 07:07, 3 years 1 month ago Blue Cap AG: operating performance in Q1 2023 in line with expectations
PRESS RELEASE published on 05/04/2023 at 07:05, 3 years 1 month ago Blue Cap AG proposes a further increase in dividend to EUR 0.90 per share following strong revenue and earnings growth in the 2022 financial year - NAV target per share for the end of 2025 at EUR 55
PRESS RELEASE published on 03/07/2023 at 07:08, 3 years 3 months ago Blue Cap AG with strong growth in revenue and earnings in the 2022 financial year
Published on 06/26/2026 at 13:00, 43 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 12 hours 3 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 14 hours 13 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 15 hours 13 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/26/2026 at 13:32, 11 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 12 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 13 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 13:00, 43 minutes ago Schweizer Electronic and Ascent Circuits Plan Strategic Indo-German PCB Cooperation
Published on 06/26/2026 at 07:00, 6 hours 43 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 6 hours 43 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 18 hours 58 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 19 hours 13 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
